Satellos Bioscience Inc (MSCL.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 85 | 44 | 1 | 0 | 1 |
| Accounts receivable | 209 | -144 | -17 | -62 | 159 |
| Other Working Capital | 133 | -1,214 | 147 | 446 | 146 |
| Other Operating Activity | -1,417 | -1,025 | -394 | -607 | -377 |
| Operating Cash Flow | $-989 | $-2,339 | $-262 | $-223 | $-70 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | -6 | 1,369 | -5,847 | 0 | 0 |
| Investing Cash Flow | $-6 | $1,369 | $-5,847 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 146 | N/A | N/A | N/A |
| Common Stock Issued | -103 | 5,465 | N/A | 123 | N/A |
| Other Financing Activity | 1 | 0 | 5,856 | 0 | 0 |
| Financing Cash Flow | $-101 | $5,611 | $5,856 | $123 | $0 |
| Exchange Rate Effect | N/A | 0 | 8 | 0 | -13 |
| Beginning Cash Position | 4,918 | 276 | 1,696 | 568 | 351 |
| End Cash Position | 3,821 | 4,918 | 1,451 | 468 | 268 |
| Net Cash Flow | $-1,096 | $4,642 | $-254 | $-101 | $-70 |
| Free Cash Flow | |||||
| Operating Cash Flow | -989 | -2,339 | -262 | -223 | -70 |
| Free Cash Flow | -989 | -2,339 | -262 | -223 | -70 |